CIK 0001855485 · <br>Emerging growth company
Calidi Biotherapeutics, Inc.
Sign in to watch- Tickers
- CLDI CLDWW
- Exchange
- NYSE, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862967193
- Phone
- 858-794-9600
- Business address
- 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Calidi Biotherapeutics, Inc., First Light Acquisition Group, Inc.
Securities
- CLDI Calidi Biotherapeutics, Inc. Common Stock NYSE
- CLDWW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-17 | Peoples George Director | Grant or award · Non-Qualified Stock Options (right to buy) | +4,000 | 4,000 | ||
| 2026-08-17 | Stewart Alan R. Director | Grant or award · Non-Qualified Stock Options (right to buy) | +4,000 | 4,000 | ||
| 2026-08-17 | Leftwich Scott Director | Grant or award · Non-Qualified Stock Options (right to buy) | +4,000 | 4,000 | ||
| 2026-08-17 | Jackson Andrew C. Chief Financial Officer | Grant or award · Stock Options (right to buy) | +14,000 | 14,000 | ||
| 2026-08-17 | Schoeneck James A Director | Grant or award · Non-Qualified Stock Options (right to buy) | +5,000 | 5,000 | ||
| 2026-08-17 | Poma Eric E Chief Executive Officer | Grant or award · Stock Options (right to buy) | +32,000 | 32,000 | ||
| 2026-08-17 | Fernandez Santidrian Antonio Chief Scientific Officer | Grant or award · Stock Options (right to buy) | +16,000 | 16,000 | ||
| 2026-08-17 | Sanders Corazon (Corsee) D. Director | Grant or award · Non-Qualified Stock Options (right to buy) | +6,000 | 6,000 | ||
| 2025-12-12 | Camaisa Allan Director | Sale | −850 | $1.46 | $1K | 76,952 |
| 2025-09-03 | Poma Eric E Chief Executive Officer | Grant or award · Stock Options (right to buy) | +10,000 | 10,000 | ||
| 2025-09-03 | Jackson Andrew C. Chief Financial Officer | Grant or award · Stock Options (right to buy) | +30,000 | 30,000 | ||
| 2025-09-03 | Fernandez Santidrian Antonio Chief Scientific Officer | Grant or award · Stock Options (right to buy) | +35,000 | 35,000 | ||
| 2025-08-21 | Schoeneck James A Director | Purchase | +75,000 | $2.00 | $150K | 76,134 |
| 2025-08-21 | Schoeneck James A Director | Purchase · Warrant (right to buy) | +75,000 | 75,000 | ||
| 2025-08-21 | Poma Eric E Chief Executive Officer | Purchase | +25,000 | $2.00 | $50K | 25,000 |
| 2025-08-21 | Poma Eric E Chief Executive Officer | Purchase · Warrant (right to buy) | +25,000 | 25,000 | ||
| 2025-08-21 | Leftwich Scott Director | Purchase | +125,000 | $2.00 | $250K | 130,650 |
| 2025-08-21 | Leftwich Scott Director | Purchase · Warrant (right to buy) | +125,000 | 125,000 | ||
| 2025-08-21 | Jackson Andrew C. Chief Financial Officer | Purchase | +2,500 | $2.00 | $5K | 2,500 |
| 2025-08-21 | Jackson Andrew C. Chief Financial Officer | Purchase · Warrant (right to buy) | +2,500 | 2,500 |
Page 1 of 4 · 78 trades